PAVmed Inc.
PAVM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001624326
No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in PAVmed Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +5 vs. Q3 2024
- Shares held
- 1.04M
- −78.8K (−7.0%) vs. Q3 2024
- Total value
- $653.8K
- −$724.8K (−52.6%) vs. Q3 2024
- New holders
- 6
- 3 more added
- Sold out
- 1
- 9 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PAVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $5.56M |
| Q1 2026 | 21 | $5.26M |
| Q4 2025 | 32 | $468.8K |
| Q3 2025 | 36 | $677.4K |
| Q2 2025 | 32 | $755.8K |
| Q1 2025 | 31 | $873.5K |
| Q4 2024 | 26 | $653.8K |
| Q3 2024 | 22 | $1.38M |
| Q2 2024 | 26 | $931.9K |
| Q1 2024 | 24 | $2.03M |
| Q4 2023 | 26 | $3.10M |
| Q3 2023 | 65 | $3.67M |
| Q2 2023 | 58 | $3.78M |
| Q1 2023 | 61 | $3.76M |
| Q4 2022 | 64 | $4.62M |
| Q3 2022 | 73 | $10.9M |
| Q2 2022 | 76 | $11.5M |
| Q1 2022 | 96 | $27.0M |
| Q4 2021 | 108 | $65.5M |
| Q3 2021 | 109 | $198.9M |
| Q2 2021 | 101 | $134.7M |
| Q1 2021 | 92 | $80.8M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding PAVmed Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Manhattan Co | 700,000 | $439.3K | 0.00% | +100,000+16.7% | Added |
| Vanguard Group Inc | 81,494 | $51.2K | 0.00% | −199,521−71.0% | Reduced |
| Geode Capital Management, LLC | 79,470 | $49.9K | 0.00% | −3,026−3.7% | Reduced |
| BlackRock, Inc. | 72,660 | $45.6K | 0.00% | −2,252−3.0% | Reduced |
| Obermeyer Wood Investment Counsel, LLLP | 21,500 | $13.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 20,854 | $13.1K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 12,787 | $8.02K | 0.00% | +12,778+141,977.8% | Added |
| Northern Trust Corp | 11,706 | $7.35K | 0.00% | 00.0% | Unchanged |
| Exencial Wealth Advisors, LLC | 10,900 | $6.84K | 0.00% | +10,900 | New |
| XML Financial, LLC | 10,067 | $6.32K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 4,792 | $3.01K | 0.00% | −42−0.9% | Reduced |
| CWM, LLC | 4,672 | $3.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,520 | $2.84K | 0.00% | +808+21.8% | Added |
| Wells Fargo & Company | 2,352 | $1.48K | 0.00% | −433−15.5% | Reduced |
| Group One Trading, L.P. | 2,224 | $1.40K | 0.00% | +2,224 | New |
| CIBC Private Wealth Group, LLC | 836 | $518 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 349 | $218 | 0.00% | −209−37.5% | Reduced |
| Allworth Financial LP | 295 | $175 | 0.00% | −152−34.0% | Reduced |
| SBI Securities Co., Ltd. | 108 | $68 | 0.00% | +108 | New |
| Parallel Advisors, LLC | 78 | $49 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 74 | $46 | 0.00% | −42−36.2% | Reduced |
| Jones Financial Companies LLLP | 29 | $18 | 0.00% | +29 | New |
| JPMorgan Chase & Co | 19 | $12 | 0.00% | −1−5.0% | Reduced |
| Synergy Financial Management, LLC | 7 | $9 | 0.00% | +7 | New |
| IFP Advisors, Inc | 6 | $4 | 0.00% | +6 | New |
| Steward Partners Investment Advisory, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Thompson Investment Management, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| M&R Capital Management Inc | – | – | – | – | Not filed |